GlassScriptPhysician profile
Kenneth P Collins
NPI 1679504906
$4,898.47
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,792 · 2020: $578 · 2021: $1,179 · 2022: $1,264 · 2023: $85.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $85.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $85.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $1,014.15 | 2019-2022 | |
| Astellas Pharma US INC | $557.21 | 2019-2023 | |
| Janssen Biotech, INC. | $478.88 | 2019-2022 | |
| Abbvie INC. | $349.76 | 2019-2022 | |
| Teleflex LLC | $311.65 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $310.10 | 2019-2022 | |
| Antares Pharma, INC. | $296.48 | 2019-2022 | |
| Zyla Life Sciences, INC. | $213.29 | 2019-2020 | |
| Pfizer INC. | $137.73 | 2019-2020 | |
| Blue Earth Diagnostics | $130.28 | 2019-2022 | |
| Medtronic, INC. | $125.43 | 2022 | |
| Boston Scientific Corporation | $124.52 | 2021-2022 | |
| Convatec INC. | $109.58 | 2019-2022 | |
| Caldera Medical, INC | $98.70 | 2022 | |
| 180 Medical, INC. | $84.37 | 2020-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $66.33 | 2019-2021 | |
| Allergan, INC. | $64.44 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $47.89 | 2022 | |
| Olympus America INC. | $47.34 | 2019-2022 | |
| Amgen INC. | $41.16 | 2020-2022 | |
| Medtronic USA, INC. | $36.54 | 2020 | |
| Clarus Therapeutics INC. | $34.27 | 2021 | |
| Endo Pharmaceuticals INC. | $26.57 | 2020-2022 | |
| Ferring Pharmaceuticals INC. | $23.72 | 2019 | |
| Merck Sharp & Dohme LLC | $23.22 | 2022 | |
| Genzyme Corporation | $21.60 | 2020 | |
| Coloplast Corp | $18.62 | 2022 | |
| Alnylam Pharmaceuticals INC. | $18.46 | 2022 | |
| Neotract INC. | $16.70 | 2019 | |
| Urogen Pharma, INC. | $16.48 | 2021 | |
| Agiliti Surgical, INC. | $15.36 | 2019 | |
| Axonics, INC. | $14.73 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $11.73 | 2021 | |
| Eisai INC. | $11.18 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.